- PROFESSOR AND SYSTEM CHAIR | Dermatology
- Hospital Affiliation
- The Mount Sinai Hospital
Dr. Mark Lebwohl graduated summa cum laude from Columbia College in 1974 and graduated from Harvard Medical School in 1978. He completed residencies in internal medicine and dermatology, both at Mount Sinai.
Dr. Lebwohl has been practicing dermatology since 1983. He is professor and chairman of the Department of Dermatology at The Mount Sinai School of Medicine. Dr. Lebwohl has served as president of the New York Dermatological Society, the Manhattan Dermatologic Society, and the New York State Society of Dermatology, and as chairman of the Dermatology Section of the New York Academy of Medicine. Dr. Lebwohl has served as chairman of the Psoriasis Task Force of the American Academy of Dermatology, and has directed the AAD's annual Psoriasis Symposium, Diagnostic Update Symposium and Therapeutics Symposium.
Dr. Lebwohl is chairman of the Medical Board of the National Psoriasis Foundation. He is the founding editor of Psoriasis Forum as well as medical editor of the bulletin of the National Psoriasis Foundation, Psoriasis Advance. He is on the editorial board of the Journal of the American Academy of Dermatology and is editor of the Dermatology Section of Scientific American Medicine, now called ACP Medicine. Dr. Lebwohl has chaired numerous symposia and has written or edited several books including the first atlas devoted entirely to cutaneous manifestations of systemic disease, and the leading book on dermatologic therapy, Treatment of Skin Disease. His books have been translated into numerous foreign languages, including French, Portuguese, Chinese and Polish. Other books include Difficult Diagnoses in Dermatology and Psoriasis. He has authored or co-authored over 500 publications including articles, chapters and abstracts. Dr. Lebwohl is actively involved in clinical trials of many new dermatologic treatments.In The News
Dr. Lebwohl discusses skin cancer in The Daily News feature The Daily Check Up. View the PDF.
American Board of Dermatology
American Board of Internal Medicine
- Actinic Keratosis
- Alopecia Areata
- Cutaneous Lymphoma
- Skin Biopsy
- Skin Cancer
- Skin Care
MD, Harvard Medical School
Residency, Internal Medicine
Mount Sinai Hospital
Mount Sinai Hospital
English, Hebrew, Spanish
America's Top Doctors
New York Magazine
American Academy of Dermatology
Best Teacher & Mentor of the Millenium
Dermatology Residents, Mount Sinai
President's Volunteer Service Award
American Academy of Dermatology Bronze Award
Leadership Circle for Volunteerism
Lebwohl M, editor. Difficult Diagnoses in Dermatology (1988). New York, Churchill Livingston;.
Lebwohl M, Zanolli M, editors. Psoriasis (1995). Philadelphia, Dermatologic Clinics of North America. W. B. Saunders;.
Lebwohl M. Atlas of the Skin and Systemic Disease (1995). New York, Churchill Livingstone;.
Lebwohl MG. The Skin and Systemic Disease: A Color Atlas and Text, 2nd edition (2004). New York, Churchill Livingstone;.
Koo JM, Lebwohl MG, Lee CS, editors. Mild-to-Moderate Psoriasis (2006). New York, Informa Healthcare;.
Koo JM, Lebwohl MG, Lee CS. Mid-to-Moderate Psoriasis (2008). New York, Informa Healthcare;.
Koo JM, Lebwohl MG, Lee CS. Moderate-to-Severe Psoriasis (2009). New York, Informa Healthcare;.
Lebwohl M, Heymann WR, Berth-Jones J, Coulson I, editors. Treatment of Skin Disease, 3rd edition (2010). London, Mosby;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Lebwohl during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Actelion Pharmaceuticals Ltd.
- Applied Biology, Inc.
- Celsus Therapeutics Plc
- Columbia Laboratories, Inc.
- Coronado Biosciences
- Covagen AG
- Forward Pharma
- Genentech, Inc.
- Meda Pharmaceuticals
- Merck & Co., Inc.
- Onset Dermatologics LLC
- Pfizer Inc.
- PharmAthene, Inc.
- Sandoz (Hexal AG)
- Taro Pharmaceuticals U.S.A., Inc.
- Thesan Pharmaceuticals
- UCB S.A.
- Valeant Pharmaceuticals International, Inc.
- Xoma (US) LLC
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- AbGenomics International Inc.
- Amgen Inc.
- CanFite BioPharma Ltd.
- Eli Lilly and Company
- Janssen Biotech, Inc., formerly Centocor Biotech, Inc.
- LEO Pharma Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.